BioMarin Pharmaceutical Inc. buy Wolfe Research
Start price
15.11.24
/
50%
€60.78
Target price
15.11.25
€89.95
Performance (%)
-22.26%
End price
16.11.25
€47.25
Summary
This prediction ended on 16.11.25 with a price of €47.25. The price of BioMarin Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -22.26%. Wolfe_Research has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -1.003% | -1.003% | -28.278% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Wolfe_Research for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $95.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Wolfe_Research gewählte maximale Laufzeit wurde überschritten
Current prediction by Wolfe_Research for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€49.93
15.07.25
15.07.25
€81.42
15.07.26
15.07.26
-9.07%
12.12.25
12.12.25
